Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H W Herr

Showing results (251-260 of 272) with videos related to

Pageof 28
Sort By:
The Journal of Urology|July 1, 1987
Fertility status of patients with clinical stage I testis tumors on a surveillance protocolP R Carroll, M J Morse, W F Whitmore, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1994
Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancerZ F Zhang, A S Sarkis, C Cordon-Cardo, et al.
The Journal of Urology|February 1, 1990
Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformationJ Sheinfeld, V E Reuter, M R Melamed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVACA S Sarkis, D F Bajorin, V E Reuter, et al.
Cancer Research|October 1, 1985
Effect of intravesical Bacillus Calmette-Guérin on detection of a urothelial differentiation antigen in exfoliated cells of carcinoma in situ of the human urinary bladderJ L Huffman, Y Fradet, C Cordon-Cardo, et al.
The Journal of Urology|March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesionH I Scher, A Yagoda, H W Herr, et al.
European Urology|January 1, 1988
Chemotherapeutic management of invasive bladder carcinomaC N Sternberg, A Yagoda, H I Scher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-upP K Schultz, H W Herr, Z F Zhang, et al.
The Journal of Urology|March 1, 1985
Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urotheliumC N Sternberg, A Yagoda, H I Scher, et al.
Cancer|December 15, 1989
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapseC N Sternberg, A Yagoda, H I Scher, et al.
Pageof 28

Showing results (251-260 of 272) with videos related to

Sort By:
Pageof 28
The Journal of Urology|July 1, 1987
Fertility status of patients with clinical stage I testis tumors on a surveillance protocolP R Carroll, M J Morse, W F Whitmore, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1994
Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancerZ F Zhang, A S Sarkis, C Cordon-Cardo, et al.
The Journal of Urology|February 1, 1990
Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformationJ Sheinfeld, V E Reuter, M R Melamed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVACA S Sarkis, D F Bajorin, V E Reuter, et al.
Cancer Research|October 1, 1985
Effect of intravesical Bacillus Calmette-Guérin on detection of a urothelial differentiation antigen in exfoliated cells of carcinoma in situ of the human urinary bladderJ L Huffman, Y Fradet, C Cordon-Cardo, et al.
The Journal of Urology|March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesionH I Scher, A Yagoda, H W Herr, et al.
European Urology|January 1, 1988
Chemotherapeutic management of invasive bladder carcinomaC N Sternberg, A Yagoda, H I Scher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-upP K Schultz, H W Herr, Z F Zhang, et al.
The Journal of Urology|March 1, 1985
Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urotheliumC N Sternberg, A Yagoda, H I Scher, et al.
Cancer|December 15, 1989
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapseC N Sternberg, A Yagoda, H I Scher, et al.
Pageof 28